Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Retrograde degeneration of visual pathway: hemimacular thinning of retinal ganglion cell layer in progressive and active multiple sclerosis.
Movement disorders in multiple sclerosis and other demyelinating diseases.
Induction of endogenous Type I interferon within the central nervous system plays a protective role in experimental autoimmune encephalomyelitis.
Autoantibodies in neuroimmunological diseases; relevance of fine specificity.
Selective accumulation of pro-inflammatory T cells in the intestine contributes to the resistance to autoimmune demyelinating disease.
Mast Cell and Autoimmune Diseases.
Multifocal VEP assessment of optic neuritis evolution.
Adult-Onset Leukoencephalopathies.
Effects of pooled human immunoglobulins in an animal model of neuromyelitis optica with chronic application of autoantibodies to aquaporin 4.
Monoclonal antibodies as disease modifying therapy in multiple sclerosis.
Progressive resistance therapy is not the best way to rehabilitate deficits due to multiple sclerosis: Commentary.
Acute liver toxicity due to methylprednisolone: Consider this diagnosis in the context of autoimmunity.
Detecting deoxyhemoglobin in spinal cord vasculature of the experimental autoimmune encephalomyelitis mouse model of multiple sclerosis using susceptibility MRI and hyperoxygenation.
Dynamic molecular monitoring of retina inflammation by in vivo Raman spectroscopy coupled with multivariate analysis.
Cognitive and Clinical Dysfunction, Altered MEG Resting-State Networks and Thalamic Atrophy in Multiple Sclerosis.
Type I IFN receptor controls activated TYK2 in the nucleus: Implications for EAE therapy.
Examining the effects of comorbidities on disease-modifying therapy use in multiple sclerosis.
Inhibition of Myelin-Cleaving Poteolytic Activities by Interferon-Beta in Rat Astrocyte Cultures. Comparative Analysis between Gelatinases and Calpain-II.
A single dose of a neuron-binding human monoclonal antibody improves brainstem NAA concentrations, a biomarker for density of spinal cord axons, in a model of progressive multiple sclerosis.
Ocular Toxicities of MEK inhibitors and other targeted therapies.
Co-occurrence of multiple sclerosis and Thomsen's myotonia: a report of two cases.
Pathophysiology, assessment and management of multiple sclerosis spasticity: an update.
The conceptualization and development of a patient-reported neurogenic bladder symptom score.
Best Practices for Network Meta-Analysis Methodology: Comparative Effectiveness of Interferon-Beta Therapies In Relapsing-Remitting Multiple Sclerosis.
Lyme disease associated neuroretinitis - Case report.

Pages